Miracle Mile Advisors’s Cognizant CTSH Stock Holding History

Miracle Mile Advisors’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,405	Closed	-$283K	–	903
2025 Q4	$283K	Buy	+3,405	New	+$255K	﹤0.01%	732

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Miracle Mile Advisors's CTSH Position: Q1 2026 in Review

Miracle Mile Advisors sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 3,405 shares — an estimated $283K sold.

Miracle Mile Advisors first reported a position in CTSH in Q4 2025 and held it in 1 quarter. The position peaked at $283K in Q4 2025. 993 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Miracle Mile Advisors reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
Miracle Mile Advisors sold 3,405 Cognizant shares in Q1 2026, an estimated $283K.
Miracle Mile Advisors first reported a position in Cognizant in Q4 2025 and held it in 1 quarter.
Miracle Mile Advisors's Cognizant position peaked at $283K in Q4 2025.
993 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.